{"id":"W1974638172","doi":"10.1007/s10637-012-9865-z","title":"REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":false,"ca_institutions":"Calgary Laboratory Services; Baker Hughes (Canada); Oncolytics Biotech (Canada); Alberta Cancer Foundation","funders":"Oncolytics Biotech","keywords":"Medicine; Oncolytic virus; Tolerability; Gastroenterology; Toxicity; Internal medicine; Adverse effect; Clinical trial; Cancer; Progressive disease; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008365326,0.001581955,0.001329092,0.0003707114,0.0003161932,0.00107107,0.0008196629,0.001167175,0.004189499],"category_scores_gemma":[0.0005525703,0.0004017266,0.001298362,0.00027458,0.0008271376,0.0006843481,0.0002806235,0.003866246,0.0009002609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007876746,"about_ca_system_score_gemma":0.001082223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001649019,"about_ca_topic_score_gemma":0.003581172,"domain_scores_codex":[0.9998003,0.00006421577,0.000006415068,0.0000405061,0.00001625079,0.00007235738],"domain_scores_gemma":[0.9996828,0.00007267445,0.00005355188,0.00002846705,0.00001321454,0.0001493333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4962568,0.05562948,0.004357738,0.002113353,0.002186581,0.0004236121,0.0005916462,0.006888844,0.1351195,0.00216533,0.0138978,0.2803694],"study_design_scores_gemma":[0.5869948,0.3741073,0.008500037,0.0001145896,0.0007761572,0.000525094,0.0001624398,0.002714812,0.0156759,0.0006934845,0.009659557,0.00007585171],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841525,0.004621918,0.001267796,0.001295439,0.0003643759,0.001481435,0.001552545,0.0003365125,0.004927461],"genre_scores_gemma":[0.9798791,0.004411222,0.00184867,0.001281601,0.0001517303,0.001543899,0.003294756,0.00009713045,0.007491915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004189499,"threshold_uncertainty_score":0.01401526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01760091088536014,"score_gpt":0.3095962140356946,"score_spread":0.2919953031503345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}